DDIT3 and diffuse large B-cell lymphoma: In this independent subset of DLBCL patients who were treated with either CHOP or R‐CHOP, the new model could stratify each group into cohorts with significantly different OS rates (Fig. 5H–J), which were similar with the training data stratified by the new algorithm or GEP method (Fig. 5B, C, E and F).